Open AccessRamelteon
Author(s) -
Matthew W. Johnson,
Patricia E. Suess,
Roland R. Griffiths
Publication year - 2006
Publication title -
archives of general psychiatry
Language(s) - English
Resource type - Journals
eISSN - 1538-3636
pISSN - 0003-990X
DOI - 10.1001/archpsyc.63.10.1149
Subject(s) - sedative , triazolam , placebo , psychology , sedation , psychomotor learning , anesthesia , medicine , benzodiazepine , cognition , psychiatry , receptor , alternative medicine , pathology
Ramelteon is a novel MT1 and MT2 melatonin receptor selective agonist recently approved for insomnia treatment. Most approved insomnia medications have potential for abuse and cause motor and cognitive impairment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom